FDA’s Project Optimus aims to transform early cancer researchNovember 14, 2023PharmacyALLAMLCMLDLBCLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Phase 2 data: Inotuzumab, approved in adults with B-ALL, shows promise in kids, tooFebruary 11, 2020ALLLeukemia, Myelodysplasia, Transplantation
Phase 2 study shows regimen benefit with dasatinib in Ph+ALL therapyJanuary 22, 2020ALLTransplantation
Promising early efficacy of venetoclax/navitoclax in r/r acute lymphoblastic leukemiaJanuary 15, 2020ALLLeukemia, Myelodysplasia, TransplantationPediatrics
Chemo-free induction-consolidation protocol for Ph+ ALL improved survivalJanuary 14, 2020ALLLeukemia, Myelodysplasia, Transplantation
CAR T cells produce complete responses in T-cell malignanciesJanuary 7, 2020ALLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
CAR T-cell ‘cocktail’ may overcome antigen escape relapseNovember 18, 2019Lymphoma & Plasma Cell DisordersALL
Researchers seek a way to predict cognitive deficits in children treated for ALLNovember 15, 2019ALLLeukemia, Myelodysplasia, TransplantationPediatrics
Exercise intolerance linked to neurocognitive dysfunction in ALLOctober 22, 2019ALLLeukemia, Myelodysplasia, Transplantation
Immunotherapies under investigation in newly diagnosed B-ALLOctober 1, 2019ALLLeukemia, Myelodysplasia, Transplantation
Stem cells gene edited to be HIV resistant treat ALL, but not HIVSeptember 11, 2019ALLLeukemia, Myelodysplasia, TransplantationTransplantation
‘Robust antitumor immune responses’ observed in pediatric ALLJune 26, 2019ALLPediatricsLeukemia, Myelodysplasia, Transplantation
SC-PEG comparable to pegaspargase in young ALL/LL patientsJune 1, 2019ALLAggressive LymphomasLeukemia, Myelodysplasia, Transplantation
